Year archive

PolyPeptide Group AG — 2021 filings

All 8 regulatory filings released by PolyPeptide Group AG (PPGN) in 2021, sourced directly from the official regulator.

8 Filings

2021 Period

2021 filings (8)

Filing	Released	Lang
PolyPeptide Group appoints Neil Thompson as Director Global Sales and Marketing and member of the Executive Committee, succeeding Jan Christensen Board/Management Information	2021-12-01	English
Results of Accelerated Bookbuild Offering of 1,500,000 Existing Shares in PolyPeptide Group AG Share Issue/Capital Change	2021-11-10	English
PolyPeptide reports strong H1 2021 revenue growth and operating leverage amidst favorable market environment and encouraging business trends Earnings Release H1 2021	2021-08-17	English
PolyPeptide Group appoints Christina Del Vecchio as General Counsel and member of the Executive Committee Board/Management Information	2021-06-25	English
PolyPeptide Group announces the exercise of the full over-allotment option Capital/Financing Update	2021-05-05	English
PolyPeptide Group prices IPO at CHF 64.00 per share and starts trading on the Swiss Stock Exchange Share Issue/Capital Change	2021-04-29	English
PolyPeptide Group launches IPO on the Swiss Stock Exchange and sets price range at CHF 57 to CHF 68 per share Share Issue/Capital Change	2021-04-21	English
PolyPeptide Group plans IPO and listing on the Swiss Stock Exchange Capital/Financing Update	2021-04-12	English